Esther Lutgens
Department of Pathology
Cardiovascular Research Institute Maastricht
University of Maastricht
Maastricht 6200 MD
Netherlands
Name/email consistency: high
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. Lutgens, E., Lievens, D., Beckers, L., Wijnands, E., Soehnlein, O., Zernecke, A., Seijkens, T., Engel, D., Cleutjens, J., Keller, A.M., Naik, S.H., Boon, L., Oufella, H.A., Mallat, Z., Ahonen, C.L., Noelle, R.J., de Winther, M.P., Daemen, M.J., Biessen, E.A., Weber, C. J. Exp. Med. (2010)
- CD40 and its ligand in atherosclerosis. Lutgens, E., Lievens, D., Beckers, L., Donners, M., Daemen, M. Trends Cardiovasc. Med. (2007)
- Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Lutgens, E., Lutgens, S.P., Faber, B.C., Heeneman, S., Gijbels, M.M., de Winther, M.P., Frederik, P., van der Made, I., Daugherty, A., Sijbers, A.M., Fisher, A., Long, C.J., Saftig, P., Black, D., Daemen, M.J., Cleutjens, K.B. Circulation (2006)
- Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Lutgens, E., Faber, B., Schapira, K., Evelo, C.T., van Haaften, R., Heeneman, S., Cleutjens, K.B., Bijnens, A.P., Beckers, L., Porter, J.G., Mackay, C.R., Rennert, P., Bailly, V., Jarpe, M., Dolinski, B., Koteliansky, V., de Fougerolles, T., Daemen, M.J. Circulation (2005)
